Drawing for NOVASEQ

USPTO serial 87474750

NOVASEQ

Reviewed by CopyMark Law Group

Reg. 6158457Status 702Renewal
Filing date
Status date
Registration date
Sep 22, 2020
Examiner
LEE, REBECCA ANN
Law office
Historical data usage

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with NOVASEQ?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Reagents, assays, enzymes, chemical preparations, biological specimens in the nature of human tissue or human body fluid, animal tissue or animal body fluid, cultures of microorganisms, plant tissue and nucleotides for scientific and research use in the fields of nucleic acid sequencing, genotyping, diagnostics, clinical research, drug development, drug development research, laboratory research, scientific research, life sciences, biology, microbiology and metagenomics, biotechnology, agriculture, forensics, food safety, and genetics, not for medical or veterinary purposes; reagents kits comprised primarily of nucleotides, reagents, enzyme substrates, buffers, chemical preparations, biological preparations in the nature of human tissue or human body fluid, animal tissue or animal body fluid, cultures of microorganisms, plant tissue and enzymes for scientific and research use in the fields of nucleic acid sequencing, genotyping, diagnostics, clinical research, drug development, drug development research, laboratory research, scientific and research, life sciences, biology, microbiology and metagenomics, biotechnology, agriculture, forensics, food safety, and genetics, not for medical or veterinary purposesACTIVEJan 9, 2017
005Reagents, clinical diagnostic reagents, medical diagnostic assays for medical and diagnostic purposes, enzymes, nucleotides, buffers, chemical reagents, and biological preparations in the nature of human tissue or human body fluids, animal tissue or animal body fluids, cultures of microorganisms, or plant tissue for medical and veterinary use in the fields of medical diagnostics, veterinary diagnostics, laboratory medicine, veterinary medicine, and geneticsACTIVEJan 9, 2017
009Computer hardware and computer software for use with medical patient monitoring equipment, for receiving, processing, transmitting and displaying data in the fields of nucleic acid sequencing, genotyping, medical diagnostics, veterinary diagnostics, clinical diagnostics, medical research, veterinary research, diagnostic research, clinical research, drug development, drug development research, medical laboratory research, veterinary science and research, life sciences, biology, microbiology, biotechnology, agriculture, forensics, food safety, metagenomics, and genetics; scientific apparatus and instruments, namely, nucleic acid sequencers for laboratory use in the fields of nucleic acid sequencing, genotyping, medical diagnostics, veterinary diagnostics, clinical diagnostics, medical research, veterinary research, diagnostics, clinical research, drug development, drug development research, medical laboratory research, veterinary science and research, life sciences, biology, microbiology, biotechnology, agriculture, forensics, food safety, metagenomics, and geneticsACTIVEJan 9, 2017
010Clinical and medical diagnostic instruments, namely, nucleic acid sequencers; scientific apparatus and instruments, namely, nucleic acid sequencers for medical and veterinary use in the fields of nucleic acid sequencing, genotyping, medical diagnostics, veterinary diagnostics, clinical diagnostics, medical research, veterinary research, diagnostics, clinical research, drug development, drug development research, medical laboratory research, veterinary science and research, life sciences, biology, microbiology, biotechnology, agriculture, forensics, food safety, metagenomics, and geneticsACTIVEJan 9, 2017
042Providing on-line non-downloadable computer search engine software; providing online non-downloadable computer software for the custom design and ordering of assays, nucleic acids and reagents; software as a service (Saas), namely, hosting software for use by others for use in the custom design and ordering of assays, nucleic acids and reagents in the fields of nucleic acid sequencing, genotyping, medical diagnostics, veterinary diagnostics, clinical diagnostics, medical research, veterinary research, diagnostic research, clinical research, drug development, drug development research, medical laboratory research, veterinary science and research, life sciences, biology, microbiology, biotechnology, agriculture, forensics, food safety, metagenomics, and genetics; Nucleic acid sequencing and analysis services for scientific and research purposes; Genome sequencing and analysis services for scientific and research purposes; genetic analysis and reporting services for scientific and research purposes; installation and maintenance of computer software and database applications for others for use in the fields of nucleic acid sequencing and genotyping, medical diagnostics, clinical diagnostics, medical research, clinical research, life sciences, biology, drug development, drug development research, molecular diagnostics, laboratory medicine, biotechnology, agriculture, forensics, and geneticsACTIVEJan 9, 2017

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 18, 2026NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Aug 18, 2026C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Aug 18, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 13, 2026E815TEAS SECTION 8 & 15 RECEIVED
Oct 29, 2025EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Oct 29, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 29, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 29, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 29, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 29, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 22, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Sep 22, 2020EXPTEXPARTE APPEAL TERMINATED
Sep 22, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 21, 2020SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Aug 20, 2020CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Aug 20, 2020XAECEXAMINER'S AMENDMENT ENTERED
Aug 20, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 20, 2020GNEAEXAMINERS AMENDMENT E-MAILED
Aug 20, 2020SNEASU-EXAMINER'S AMENDMENT WRITTEN
Aug 18, 2020ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED
Aug 18, 2020EXPIEX PARTE APPEAL-INSTITUTED
Aug 18, 2020JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY
Aug 18, 2020EXAFEXPARTE APPEAL RECEIVED AT TTAB
Jul 28, 2020ATRVATTORNEY REVIEW COMPLETED
Jul 15, 2020ATRVATTORNEY REVIEW COMPLETED
Jul 10, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 7, 2020ALIEASSIGNED TO LIE
Jun 25, 2020EPPATEAS POST PUBLICATION AMENDMENT RECEIVED
Feb 27, 2020GNFNNOTIFICATION OF FINAL REFUSAL EMAILED
Feb 27, 2020GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 27, 2020CNFRSU - FINAL REFUSAL - WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 8, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Feb 6, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 6, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 31, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 31, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 31, 2019CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 24, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Dec 23, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 23, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 21, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 21, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 28, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 28, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 28, 2019CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 27, 2019SUPCSTATEMENT OF USE PROCESSING COMPLETE
Jun 27, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 14, 2019IUAFUSE AMENDMENT FILED
Jun 14, 2019EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jan 29, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 25, 2019EX2GSOU EXTENSION 2 GRANTED
Jan 25, 2019EXT2SOU EXTENSION 2 FILED
Jan 25, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 31, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 27, 2018EX1GSOU EXTENSION 1 GRANTED
Jul 27, 2018EXT1SOU EXTENSION 1 FILED
Jul 27, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 30, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 5, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 5, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 15, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 20, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Oct 20, 2017XAECEXAMINER'S AMENDMENT ENTERED
Oct 20, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 20, 2017GNEAEXAMINERS AMENDMENT E-MAILED
Oct 20, 2017CNEAEXAMINERS AMENDMENT -WRITTEN
Oct 4, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Oct 4, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 2, 2017ALIEASSIGNED TO LIE
Sep 22, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 21, 2017GEANNOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Sep 21, 2017GEAPEXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Sep 21, 2017EPENCOMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Sep 21, 2017CPEAEXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Sep 5, 2017DOCKASSIGNED TO EXAMINER
Jun 10, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 8, 2017NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance